MacKillop, J https://orcid.org/0000-0003-4118-9500
Few, L R
Stojek, M K
Murphy, C M
Malutinok, S F
Johnson, F T
Hofmann, S G
McGeary, J E
Swift, R M
Monti, P M
Article History
Received: 16 October 2014
Revised: 17 February 2015
Accepted: 23 February 2015
First Online: 7 April 2015
Competing interests
: RS is a member of the Advisory Board of D&A Pharma and has received travel expenses and honoraria from this company. He has received consulting fees from Transcept Pharmaceuticals and Pharmaceutico CT. The remaining authors declare no conflict of interest.